Examining the role of serum periostin as a prognostic marker of asthma
Not Applicable
- Conditions
- asthma
- Registration Number
- JPRN-UMIN000030674
- Lead Sponsor
- Kyoto University
- Brief Summary
High serum periostin levels at baseline may predict future requirement for highly intensive asthma treatment for type-2 inflammation, i.e., the need for increasing high dose ICS, SCS use or omalizumab. In "Assessment of serum periostin level as a predictor of requirement forintensive treatment for type-2 inflammation in asthmatics in future: A follow-up study of the KiHAC cohort".
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who expressed a denial of secondary use to other research.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method